Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

154
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
154
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

189
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
189
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

333
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
333
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

82
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
82
Menopause01:28

Menopause

149
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
149
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

264
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
264

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depression Rates Among Rheumatologists From Latin America: A PANLAR Online Survey.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
Same author

Multidisciplinary consensus on the management of patients with osteopenia and fracture risk in Spain.

BMC musculoskeletal disorders·2025
Same author

Recommendations for the prevention of fragility fractures: a consensus from international experts and Ibero-American scientific societies.

Archives of osteoporosis·2025
Same author

Optimisation of vitamin D status in global populations.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2024
Same author

Capi-score: a quantitative algorithm for identifying disease patterns in nailfold videocapillaroscopy.

Rheumatology (Oxford, England)·2024
Same author

Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases.

Drugs in context·2023

Related Experiment Video

Updated: Jun 20, 2025

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.1K

Climacteric and fibromyalgia: a review.

Luis Fernando Vidal-Neira1, José Luis Neyro2, Genessis Maldonado3

  • 1Rheumatology Service, Centro Diagnóstico de la Osteoporosis y Enfermedades Óseas, Lima, Perú.

Climacteric : the Journal of the International Menopause Society
|July 22, 2024
PubMed
Summary

Fibromyalgia and menopause share symptoms, but require separate treatment. Menopausal hormone therapy is not recommended for fibromyalgia unless the patient also has climacteric syndrome.

Keywords:
Fibromyalgiachronic painclimactericmenopausal hormone therapymusculoskeletal pain

More Related Videos

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

1.5K
Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients
11:26

Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients

Published on: July 14, 2018

17.3K

Related Experiment Videos

Last Updated: Jun 20, 2025

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.1K
Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

1.5K
Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients
11:26

Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients

Published on: July 14, 2018

17.3K

Area of Science:

  • Rheumatology
  • Gynecology
  • Endocrinology

Background:

  • Fibromyalgia (FM) and climacteric conditions exhibit overlapping epidemiological and clinical characteristics.
  • FM symptoms frequently emerge during menopause, with shared symptoms including musculoskeletal pain, arthralgia, and myalgia.
  • Hormonal changes, particularly the cessation of sex hormones during menopause, are implicated in the onset and exacerbation of FM symptoms.

Purpose of the Study:

  • To explore the relationship between fibromyalgia and climacteric conditions.
  • To differentiate management strategies for coexisting fibromyalgia and menopause.
  • To evaluate the role of menopausal hormone therapy in fibromyalgia management.

Main Methods:

  • Review of existing literature on fibromyalgia and menopausal symptoms.
  • Comparative analysis of clinical and epidemiological features.
  • Assessment of evidence for menopausal hormone therapy in fibromyalgia.

Main Results:

  • Fibromyalgia and climacteric conditions share significant clinical and epidemiological features, often with symptom onset during menopause.
  • Women with fibromyalgia may experience worsened symptoms post-menopause, particularly after hysterectomy.
  • Limited evidence supports menopausal hormone therapy for primary fibromyalgia management.

Conclusions:

  • While fibromyalgia and climacteric conditions share similarities and can coexist, they necessitate distinct management approaches.
  • Established guidelines for each condition should be followed.
  • Menopausal hormone therapy is not advised for fibromyalgia unless a concurrent climacteric syndrome is present.